Ear Infection Treatment For Dogs Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

Zymox is the best-performing ear infection treatment for dogs brand in July 2026, moving 36,000 units across 3 ASINs for 33.3% of Top 10 volume. Virbac follows with 20,000 units (18.5%), ahead of Pet MD on 20,000 units (18.5%).

With 8 brands splitting the Top 10 and 70.4% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $13.59 to $28.16, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. On the growth side, B0F8BM315W leads positive momentum with ▲ 185.7% MoM growth on 2K units, with B07WCYPZCB close behind at ▲ 133.3% MoM on 700 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.